Dr. Jing-Shan "Jennifer" Hu joined Qiming Venture Partners as Venture Partner in March 2016 and as Partner of QIMING USA Healthcare Fund. She brings extensive experience in partnering, licensing, business development, R&D and management from three pharmaceutical multinational companies & two US biotech companies. Before Qiming, she was at Bayer Healthcare Pharmaceuticals as VP and Head of (External) Innovation Center China, responsible for building partnerships for Global Drug Discovery with organizations in Greater China. Prior to that, she was Director of Licensing & External Research at Merck&Co (MSD), heading early stage partnering/licensing efforts in Greater China for Worldwide Licensing & External Research on novel drug candidates and technologies. She worked previously at Roche Palo Alto as Head of Functional Biology, at Affymetrix as Program Manager of Pharmacogenomics, and at Human Genome Sciences as Scientist of Protein Therapeutics & VEGF-2 Project Leader. While working at biotech companies, she has been successful in partnering with various organizations, including biotech industry and academia such as Stanford University. Dr. Hu obtained her post-doctoral training at Harvard Medical School, PhD degree from Univ. of Texas Graduate School of Biomedical Sciences at MD Anderson Cancer Center, and BS degree in Biochemistry from Peking Univ.